Early treatment with ß-blockers should be started in all patients surviving MI unless there are contraindications. ß-blockers should be continued for at least 6 years. Low LVEF not accompanied ...

Sodium channel blockers are used to treat ventricular arrhythmia. Class I antiarrhythmics should not be used in people with ...

According to Kiran, this can interfere with blood pressure medications and antiarrhythmics, which are used to treat abnormal heart rhythms. "The chemical causes sodium retention and potassium loss ...

antiarrhythmics, or angiotensin receptor blockers. They also may cause side effects, such as: An increased risk of bleeding, especially in people who take antiplatelet or anticoagulant drugs QT ...

antiarrhythmics, antihypertensives, benign prostatic hyperplasia medications, oral hypoglycemic agents, histamine H 2-receptor blockers, laxatives and stool softeners, muscle relaxants ...

May potentiate or be potentiated by CYP2D6 inhibitors (eg, paroxetine, fluoxetine, quinidine) or substrates (eg, tricyclics, phenothiazines, type 1C antiarrhythmics) or other highly protein-bound ...

Potentiated by CYP2D6 inhibitors (eg, quinidine, cimetidine, phenothiazines, SSRIs, Type IC antiarrhythmics); may need dose reduction. Do not initiate within 5 weeks of discontinuing fluoxetine.

The Impact of Our Diet on Medication Efficacy Key Points Many of us take medication daily or occasionally, often unaware of ...

More recently, researchers have explored these effects and other therapeutic uses, such as in attention-deficit hyperactivity disorder (ADHD). However, more research is needed to confirm its ...